After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of PTC Therapeutics Inc is $4.17B. A total of 1.0 million shares were traded on the day, compared to an average of 733.49K shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, PTCT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Utter Christine Marie sold 879 shares of PTCT for 50.10 per share on Feb 19 ’25. After the transaction, the SVP, CHIEF ACCOUNTING OFFICER now owns 63,442 company shares. In a previous transaction on Feb 20 ’25, Utter Christine Marie sold 878 shares at 50.12 per share. PTCT shares that SVP, CHIEF ACCOUNTING OFFICER owns now total 62,564.
Among the insiders who sold shares, Gravier Pierre disposed of 1,168 shares on Feb 19 ’25 at a per-share price of $50.10. This resulted in the CHIEF FINANCIAL OFFICER holding 75,603 shares of PTCT after the transaction. In another insider transaction, Gravier Pierre sold 1,167 shares at $50.12 per share on Feb 20 ’25. Company shares held by the CHIEF FINANCIAL OFFICER now total 74,436.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for PTCT in the last 3 months, the mean price target is $63.00 with high estimates of $113.00 and low estimates of $41.00. In terms of 52-week highs and lows, PTCT has a high of $55.41 and a low of $24.00.
As of this writing, PTCT has an earnings estimate of -$1.31 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$1.31 per share and a lower estimate of -$1.31.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PTCT’s latest balance sheet shows that the firm has $773.38M in Cash & Short Term Investments as of fiscal 2021. There were $1.27B in debt and $509.35M in liabilities at the time. Its Book Value Per Share was -$14.13, while its Total Shareholder’s Equity was $1.44M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Buy with a score of 3.80.
